| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr16_0401700 | Intergenic-Intergenic | chr16:89370712-89371319 | chr16:89304304-89304911 | 608 nt | 0.5411 |
| hsa_ANKRD11_0002600 | Intron-Exon-Intron | chr16:89371336-89371752 | chr16:89304928-89305344 | 417 nt | 0.6619 |
| hsa_ANKRD11_0003300 | Intron-Exon-Intron | chr16:89371614-89374137 | chr16:89305206-89307729 | 513 nt | 0.5965 |
| hsa_ANKRD11_0003400 | Intron-Exon-Intron | chr16:89371614-89379997 | chr16:89305206-89313589 | 412 nt | 0.5631 |
| hsa_ANKRD11_0003500 | Intron-Exon-Intron | chr16:89371614-89380464 | chr16:89305206-89314056 | 879 nt | 0.5097 |
| hsa_ANKRD11_0003600 | Exon-Exon | chr16:89371614-89383434 | chr16:89305206-89317026 | 506 nt | 0.5672 |
| hsa_ANKRD11_0003700 | Intron-Exon-Intron | chr16:89371614-89388410 | chr16:89305206-89322002 | 145 nt | 0.5793 |
| hsa_ANKRD11_0003800 | Intron-Exon-Intron | chr16:89371614-89389620 | chr16:89305206-89323212 | 139 nt | 0.5899 |
| hsa_ANKRD11_0003000 | Intron-Exon-Intron | chr16:89371614-89395782 | chr16:89305206-89329374 | 250 nt | 0.5000 |
| hsa_ANKRD11_0003900 | Intron-Exon-Intron | chr16:89371614-89423846 | chr16:89305206-89357438 | 282 nt | 0.5816 |
A study in mice demonstrated that the circANKRD11 is down-regulated in methamphetamine-treated primary cortical neurons and is associated with METH-induced neurotoxicity and apoptosis [Li et al. DOI:10.1016/J.Neulet.2019.02.032]. A review further confirmed its down-regulation in primary cortical neurons treated with METH, linking it to apoptotic pathways [Xu et al. DOI:10.1007/S10571-023-01323-X].